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Sequence-Specific Photomodification of DNA by an
Oligonucleotide-Phenanthrodihydrodioxin Conjugate
Kestutis G. Bendinskas,* Andreas Harsch,†,‡ R. Marshall Wilson,‡ and W. Robert Midden
Center for Photochemical Sciences, Department of Chemistry, Bowling Green State University,
Bowling Green, Ohio 43403 . Received December 19, 1997; Revised Manuscript Received May 22, 1998
We introduce a new member of a family of photochemically active oligonucleotide conjugates. A
Phenanthrodihydrodioxin (PDHD)-based agent was synthesized and covalently linked to a 5′-end of
the 9-mer oligonucleotide via a hexamethylene linker. The conjugate hybridized to a complementary
30-nucleotide-long target and efficiently cleaved it in a sequence specific manner. Up to 67% of target
was specifically damaged (51% cross-links and 16% direct cleavage). While the photosensitizer alone
nonspecifically damaged only Gs in a single-stranded target, its conjugate cross-linked to and damaged
also A, T, and C sites in a target in agreement with duplex and triplex formation.
INTRODUCTION
Therapeutic potential of covalently modified oligo-
nucleotides has driven the search for agents that can be
coupled to DNA, are easy to control, and damage specific
DNA target sites (1). One of the most frequently used
classes of such agents has been photosensitizers since
they offer the advantage of controlling the timing of the
chemical inactivation event (2).
Several photoreactive groups have been covalently
linked to oligonucleotides and their analogues (3). For
example, psoralens (Pso)1 that are able to form inter-
strand cross-links or monoadducts in double-stranded
DNA (4), often have been used as photosensitizers
coupled to oligonucleotides. Pso-pN13 was covalently
linked to target DNA and irreversibly inhibited bla gene
transcription in Escherichia coli in vitro (5). Psoralen-
methylphosphonate conjugate cross-linked with rabbit
globin mRNA 50-100% and specifically inhibited trans-
lation to the extent of 40-60% at oligomer concentrations
of 5-20 íM (6). Pso-pN16 inhibition of DraI digestion of
HIV-I DNA was 95% at 7 íM oligonucleotide concentra-
tion (7, 8). Pso-pN10 induced 100-fold more frequent
mutations in a specific region of the ì genome (9). After
UV irradiation, Pso-pN15 cross-linked and inhibited
transcription of the R-subunit of the interleukin 2 recep-
tor in vivo (10).
Another class of photosensitizers, porphyrins, linked
to oligonucleotides, produced various types of photodam-
age on a complementary target DNA (11-13). This
included oxidation of G and cross-linking of the porphyrin
conjugate to the target sequence. Both reactions gave
57% yield of total modification (20% oxidized G, and 37%
cross-linking). Guanines located close to the porphyrin
macrocycle were the most altered (11). Up to 7% of target
DNA was cross-linked, and up to 23% was cleaved by the
conjugate of sapphyrin, an extended porphyrin that
damages DNA upon irradiation with 300 and >620 nm
light (13). The conjugates of 3-azidoflavine (14) and
p-azidophenacyl (15) were photo-cross-linked to the sin-
gle- and double-stranded 27-mers and induced cleavage
after piperidine treatment. A small fraction of ellipticine
derivative photo-cross-linked with double-stranded DNA
(16). Eosin has been linked to oligonucleotides and
produced damage in double-stranded targets (17). Profla-
vin-linked oligonucleotide was able to induce 12% cleav-
age after irradiation followed by piperidine treatment
(18). Uranyl UO22+ photooxidation induced cleavage at
the ends of oligodeoxynucleotides. However, its conju-
gates failed to do so (19). Aryl azide/biotin/oligonucle-
otide derivative cross-linked to its target and was used
to quantitate triple-helix formation (20).
Considering potential benefits of photosensitizer-DNA
conjugates, it is important to search for and study new
kinds of photoreactive groups that could give high yields
of specific target DNA inactivation.
The purpose of this investigation was to prepare a
PDHD-DNA conjugate and investigate its sequence-
specific DNA damage potency. PDHDs were designed as
photoactivatable DNA-damaging agents (21-26), and
this study is a first attempt to couple them to a molecule
that will give them sequence specificity.
PDHDs are masked o-quinones: they can be made
from and release phenanthrenequinone (PAQ) when
irradiated with 425-514 and 350 nm light, respectively
(Scheme 1) (21). This release of parent PAQ is believed
to be responsible for DNA damage and cleavage. Several
PDHD analogues carrying ionic groups to make them
soluble in water have been prepared. PDHDs with
cationic groups bind to DNA with typical binding con-
stants Kass ) 2.5  104 M-1. They show hyperchromism
and a 3-7 nm bathochromic shift in the presence of DNA
which is consistent with intercalation and/or groove
binding. Cationic PDHDs efficiently relax supercoiled
…X 174 FR I DNA upon irradiation with low doses of
365 nm light under both oxygen-rich and oxygen-free
conditions. Cationic PDHDs inactivate up to 4 logs of
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Vaccinia virus. Results of transient spectroscopy, quench-
ing of DNA cleavage with dithiothreitol (DTT), and
irradiation of PDHDs in the presence of cytochrome c and
superoxide dismutase support a mechanism of DNA
damage which involves the release of excited PAQ that
is capable of hydrogen abstraction or electron transfer
and the involvement of superoxide and other radicals (21,
27). Other mechanisms of DNA damage by cationic
PDHDs, including involvement of singlet oxygen, are
possible. The relative efficiencies of different DNA-
cleaving mechanisms for different PDHDs is being in-
vestigated and will be a subject of a separate publication.
No information was available about sequence specific-
ity of PDHDs. Due to the small size, little if any
specificity was expected. Because of the relatively low
DNA binding affinity [10 times lower than ethidium
bromide, 1000 times lower than tripyridyl ruthenium
(27)] PDHDs are good candidates for use as DNA
conjugates since they should allow sequence-specific
recognition by the targeting oligonucleotide, increasing
its binding slightly, but not so much as to alter the site-
specificity provided by the sequence-recognizing oligo-
nucleotide group.
EXPERIMENTAL PROCEDURES
Preparation of Oligonucleotides. Regular oligo-
nucleotides were synthesized on PerSeptive Biosystems
Expedite Synthesizer using standard phosphoramidite
chemistry at the DNA Core Facility at the University of
Cincinnati. All oligos were purified by reverse-phase
columns and PAGE and dissolved in water to make a 20
íM solution. Target DNA was labeled at the 5′-end using
[ç-32P]ATP and T4 polynucleotide kinase. Its purity and
labeling efficiency were checked by 20% polyacrylamide
gel electrophoresis.
Synthesis of 2-[4-(6-(tert-Butyldimethylsilyloxy)-
hexyloxy)phenyl]-2-[4-methoxy-phenyl]-2,3-dihy-
drophenanthro-[9.10-b]-1,4-dioxin (2, Scheme 2).
Dihydrodioxin 1 (Scheme 2) (0.0827 g, 0.19 mmol) was
placed in a 5 mL one-necked flask and dissolved in 1.5
mL of HPLC-grade acetonitrile, followed by the addition
of 0.06 g (0.23 mmol) 18-crown-6, 0.032 g (0.23 mmol) of
potassium carbonate, and 0.078 g (0.23 mmol) of 6-(tert-
butyldimethylsilyloxy)-1-iodohexane. The reaction was
allowed to stir under nitrogen for 12 h and was then
diluted with chloroform. The solids were removed by
filtration and the solvent was evaporated. The crude
reaction mixture was purified by rotary chromatography
(7.5% ethyl acetate, 92.5% hexanes). The product 2 was
isolated as a colorless oil. Product C41H48O5Si; molar
mass: 648.9 g/mol; yield 0.0993 g (0.153 mmol), 80.5%.
1H NMR (CDCl3) ä (ppm): 8.56 (m, 2H), 8.43 (d, J ) 7.5
Hz, 1H), 8.12 (m, 1H), 7.67-7.42 (m, 8H), 6.83 (d, J )
8.6 Hz, 2H), 6.81 (d, J ) 8.6 Hz, 2H), 4.75 (s, 2H), 3.88
(t, J ) 6.5 Hz 2H), 3.74 (s, 3H), 3.59 (t, J ) 6.2 Hz, 2H),
1.72 (m, 2H), 1.54-1.35 (m, 6H), 0.88 (s, 9H), 0.03 (s,
6H). 13C NMR (CDCl3) ä (ppm): 158.8, 133.4, 133.1,
132.8, 132.5, 128.2, 128.1, 127.9, 126.9, 126.7, 126.6,
126.5, 126.2, 124.7, 122.4, 122.3, 120.8, 120.7, 114.3,
113.8, 79.3, 70.4, 67.8, 63.1, 55.2, 32.8, 29.2, 25.9, 25.8,
25.6, 18.4, -5.3. IR (CHCl3): 2933, 2858, 1633, 1610,
1583, 1512, 1462, 1335, 1251, 1178, 1089, 1009, 978, 834
cm-1. MS (m/z) 440, 208, 180, 152, 133 (base peak).
Synthesis of 2-[4-(6-Hydroxyhexyloxy)phenyl]-2-
[4-methoxy-phenyl]-2,3-dihydrophenanthro-[9.10-
b]-1,4-dioxin (3, Scheme 2). In a 5 mL round-bottom
flask, 0.0993 g (0.153 mmol) of 2 was dissolved in distilled
THF. The solution was cooled in an ice bath, then 0.184
mL of a 1 M solution of tetrabutylammonium fluoride in
hexanes (0.184 mmol) was added dropwise via syringe.
The reaction mixture was allowed to stir for 4 h at 0 °C.
Thin-layer chromatography showed complete disappear-
ance of the protected alcohol. The solution was diluted
with 10 mL of chloroform and washed twice with water.
The organic layer was collected and filtered through
magnesium sulfate, and the solvent was evaporated.
Purification was achieved by rotary chromatography
(70% ethyl acetate, 30% hexanes). The product was
isolated as a highly viscous oil. Product C35H34O5; molar
mass 534.7 g/mol; yield 0.0664 g (0.124 mmol), 81.2%.
1H NMR (CDCl3) ä (ppm): 8.56 (m, 2H), 8.43 (d, J ) 8.3
Hz, 1H), 8.11 (m, 1H), 7.67-7.41 (m, 8H), 6.83 (d, J )
8.3 Hz, 2H), 6.79 (d, J ) 8.3 Hz, 2H), 4.74 (s, 2H), 3.86
(t, J ) 6.3 Hz, 2H), 3.72 (s, 3H), 3.61 (t, J ) 6.4 Hz, 2H),
1.77-1.49 (m, 8H), 1.27 (s, 1H). 13C NMR (CDCl3) ä
(ppm): 159.2, 158.7, 133.4, 133.1, 132.8, 132.5, 128.2,
127.8, 126.9, 126.7, 126.6, 126.4, 126.2, 124.8, 122.5,
122.4, 120.8, 120.7, 114.3, 113.7, 79.3, 70.4, 67.7, 62.8,
55.2, 32.7, 29.2, 25.9, 25.5. IR (CHCl3): 3622, 3080, 2938,
2881, 1633, 1610, 1512, 1454, 1350, 1335, 1250, 1178,
1118, 1089, 1040, 949, 832 cm-1.
Synthesis of 2-[4-(6-([N,N-Diisopropyl][cyano-
ethyloxy]phosphoroxy-hexyloxy)phenyl]-2-[4-meth-
oxy-phenyl]-2,3-dihydrophenanthro-[9.10-b]-1,4-di-
oxin (4, Scheme 2). A solution of 0.0296 g (0.055 mmol)
of 3 and 0.019 mL (0.11 mmol) N,N-diisopropylethy-
lamine in 0.5 mL of distilled methylene chloride was
placed in a 2 mL microscale flask. The flask was purged
with argon, then 0.013 mL (0.058 mmol) of 2-cyanoethyl
N,N-diisopropylchlorophosphoramidite was added via
syringe. The reaction was stirred at room temperature
for 10 min, then diluted with chloroform, and the organic
layer was washed twice with small portions of water. The
organic solution was filtered through magnesium sulfate,
Scheme 1. Scho1nberg Reaction: Forward Reaction with Visible Light (425-514 nm), Reverse Reaction with UV
Light (350 nm)
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and the desired product 4 was isolated by rotary chro-
matography (50% ethyl acetate, 48.5% hexanes, 1.5%
triethylamine). Product C44H51N2O6P; molar mass 734.9
g/mol; yield 0.0338 g (0.046 mmol), 83.6%. 1H NMR
(CDCl3) ä (ppm): 8.56 (m, 2H), 8.43 (d, J ) 8.2 Hz, 1H),
8.11 (m, 1H), 7.67-7.41 (m, 8H), 6.83 (d, J ) 8.4 Hz, 2H),
6.80 (d, J ) 8.7 Hz, 2H), 4.74 (s, 2H), 3.89-3.49 (m, 11H,
-OCH3, 2 -CHd, 3 -CH2), 2.57 (t, J ) 6.3 Hz, 2H),
1.75-1.25 (m, 8H), 1.15 (dd, J ) 6.5 Hz, J′) 4.6 Hz, 12H).
13C NMR (CDCl3) ä (ppm): 159.1, 158.7, 133.3, 133.1,
132.8, 132.5, 128.1, 126.9, 126.7, 126.6, 126.5, 126.1,
124.7, 122.4, 122.3, 120.8, 120.7, 117.6, 114.2, 113.7, 79.3,
70.4, 67.7, 63.6, 63.4, 58.4, 58.1, 55.1, 43.1, 42.8, 31.1,
31.0, 29.7, 29.1,25.7, 25.6, 24.6, 24.5, 24.4, 20.3, 20.2. 31P
NMR (CDCl3) ä (ppm): (external standard, H3PO4) 148.0.
IR (CHCl3): 3080, 2968, 2936, 2248, 1633, 1610, 1512,
1461, 1335, 1250, 1179, 1088, 1040, 978 cm-1. MS (m/z)
(M + H)+ observed, 735.3; calculated: 735.3. After its
synthesis, the phosphoramidite 4 was tested on TLC
plates for its stability in 30% ammonia and 20 mM I2 in
Scheme 2. Synthesis of PDHD-Phosphoramidite Precursor 4a
a 1, phenanthrodihydrodioxin (PDHD) derivative; 2, 2-[4-(6-(tert-butyldimethylsilyloxy)hexyloxy)phenyl]-2-[4-methoxy-phenyl]-
2,3-dihydrophenanthro-[9.10-b]-1,4-dioxin, 3; 2-[4-(6-hydroxyhexyloxy)phenyl]-2-[4-methoxy-phenyl]-2,3-dihydrophenanthro-[9.10-
b]-1,4-dioxin; 4, 2-[4-(6-([N,N-diisopropyl][cyanoethyloxy]phosphoroxy-hexyloxy)phenyl]-2-[4-methoxy-phenyl]-2,3-dihydrophenan-
thro-[9.10-b]-1,4-dioxin; 5, the PDHD conjugate; and 6, water soluble photosensitizer PDHD.
Scheme 3a
a (a) Sequences of the target DNA (30A) and the complemen-
tary oligonucleotides 30T and 9T; (b) alignment of the target
and the conjugates. The bottom strand binds to the target in
antiparallel orientation via Watson-Crick base-pairing. The
third strand binds in parallel orientation via Hoogsteen base-
pairing (5). The bases in the target are numbered from the 5′-
end.
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THF/pyridine/water, then carefully dehydrated, and dis-
solved in acetonitrile to make a 0.1 M solution.
Synthesis of an Oligonucleotide-PDHD Conju-
gate (5, Scheme 2). The 9-mer TTTTCTTTT was
synthesized in the DNA Core Facility at the University
of Cincinnati by standard synthesis on a 1 íM scale using
a ABI 394 synthesizer with the following changes: an
easily deprotected phosphoramidite of dC was used, and,
after the 5′-end deprotection step of the oligonucleotide,
TCA was washed from the column with acetonitrile for
2 min (4 times longer than usual) to minimize exposure
of the photosensitizer to acid. The coupling of this resin-
bound oligonucleotide to PDHD-phosphoramidite was
performed in 0.5 M tetrazole in acetonitrile for 3 min (6
times longer than usual) to increase coupling efficiency.
Instead of standard 0.1 M I2, 20 mM I2 in THF/pyridine/
water was used for the oxidation step. The detritylation
step, since it involves the use of TCA, was excluded at
the end of the program. After cleaving from the column
in aqueous ammonia, the conjugate was deprotected for
1 h at room temperature, purified using a reversed-phase
cartridge, and checked using PAGE. The conjugate’s
UV-vis and fluorescence spectra were recorded with a
Hewlet Packard 8452A Diode Array Spectrophotometer
and SPEX 1680 0.22M Double Spectrometer, respec-
tively. Mass spectrum of the conjugate was taken on
PerSeptive Biosystems Voyager-DE MALDI-TOF as the
sum of 64 nitrogen laser shots at 336 nm using 3-hy-
droxypicolinic acid as a matrix.
Unless stated otherwise, all chemicals for syntheses
were purchased from Aldrich. Solvents were purified
according to standard procedures. 1H and13C and 31P-
NMR spectra were recorded with a Bruker AC 250. IR
spectra were recorded with a Perkin-Elmer 1600 Series
FTIR in a solution cell (path length, 0.2 mm). Low
resolution mass spectra were taken with a Hewlett-
Packard HP 5995, electron impact 70 eV or a Finnigan
Mat LCQ Ion Trap, high-resolution mass spectra were
obtained on a Kratos MS 801-DS 55. Unless stated
otherwise, preparative chromatography separations were
performed using centrifugal chromatography with a
Chromatotron and plates were coated with E. Merck
silica gel 60-PF254.
UV-Melting Experiments. The change of absorbance
at 260 nm was measured with a Cary 219 Spectropho-
tometer interfaced to an IBM computer with an Intel
80386 processor that also controlled a Haake A80 circu-
lating water bath and collected temperature data from
a thermocouple using custom software. The sample
chamber was purged with N2. DNA was dissolved in SCP
(1 M NaCl, 10 mM sodium phosphate, pH 7.4) buffer,
heated to 98 °C, and cooled slowly, at 0.5 °C/min rate, to
4 °C.
Maxam and Gilbert Chemical Sequencing. The
target DNA was sequenced using standard procedures
(28) with the following changes: both, GA and TC
reactions with formic acid and hydrazine, respectively,
were incubated for 2 h at room temperature, and the
treatment with 10% piperidine was performed at 90 °C
for 60 min for GA and for 50 min for TC reaction.
Photochemical Cleavage Reaction. Radioactively
labeled target DNA at 10 nM concentration was mixed
with PDHD or PDHD- conjugate at 0-10 íM in 20 íL of
SCP buffer. Carrier calf thymus DNA (2 íg) was
included where indicated. Samples were heated at 55
°C for 1 min, cooled to 4 °C at the rate of 1 °C/min in a
thermal cycler, and incubated for 1 h at 4 °C. All of the
Figure 1. Absorbance spectra of 1 íM 9T DNA (top panel), 5
íM PDHD 6 (middle panel), and 1 íM conjugate 5 (bottom
panel).
Figure 2. A photograph of the UV-shadowing experiment.
Lane 1: 1 nmol of PDHD 6; lane 2: 1 nmol of PDHD 6 + 1
nmol of 9T DNA, gray spot; lane 3: 1 nmol of the conjugate 5,
bright blue spot.
Figure 3. Fluorescence spectra of 2.5 íM PDHD, excitation
at 354 nm.
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above were performed with dimmed lights. Samples
were placed on Parafilm on a glass table surrounded by
SCP buffer and enclosed in a Pyrex glass dish. Samples
were irradiated for 1-12 h at 4 °C in a RAYONET
Preperative Type RS Photochemical Reactor equipped
with a cooling fan and heated-cathode 350 nm emission
lamps from Southern New England Ultraviolet Co.
Irradiance at the sample was 2 mW/cm2. The reaction
was stopped by turning off the lamps. Radicals were
quenched by addition of 2 íL of 0.1 M DTT. DNA was
treated in 10% piperidine for 1 h, triple-lyophilized,
redissolved in 10 íL of 80% formamide loading buffer,
and run on 20% polyacrylamide, 8 M urea gel. After
electrophoresis, the gel was covered with saran wrap and
exposed to Kodak X-ray film. Films were scanned using
a Bio-Rad GS-670 imaging densitometer. The data were
processed on an IBM computer with an Intel 80386
processor using Molecular Analyst software.
RESULTS AND DISCUSSION
The M13 genome was chosen as a target for the
studies. The sequence AAAAGAAAA (between bases
5983 and 5992 of M13, traditional numbering) was
selected for several reasons. It is a unique site in the
genome. It is a potential site not only for double-strand
but also for triple-strand formation. It is a part of the
lac i gene which enables blue/white plaque screening for
later studies. A 30-mer 5′-TCTCGCTGGTGAAAAGA-
AAAACCACCCTGG-3′ (30A, Scheme 3a) containing the
target sequence AAAAGAAAA was synthesized and
labeled with 32P at the 5′-end. The conjugate that binds
to such a target should have a polypyrimidine sequence
5′-TTTTCTTTT-3′ to be capable of both double- and
triple-strand formation (Scheme 3b). The hexamethylene
linker was used to give the photosensitizer PDHD some
degree of freedom to interact with the target. Two
oligonucleotides complementary to the target were syn-
Figure 4. Irradiation of the target 30A DNA with and without PDHD 6/conjugate 5 for different times and concentrations. Lanes:
(1) GA Maxam-Gilbert reaction of the target, (2) TC Maxam-Gilbert reaction, (3 and 12) target irradiated for 12 h and treated with
piperidine (as the rest of the lanes, unless otherwise indicated), (4 and 11) target not irradiated and not treated, (5-10 and 13-20)
target irradiated (hî) for indicated times with indicated concentrations of PDHD or PDHD-conjugate.
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thesized, a 30-mer 30T and a 9-mer 9T (Scheme 3a) for
the appropriate control experiments.
The PDHD derivative 1 (Scheme 2) was synthesized
in a five step procedure (27). This synthesis will be
reported elsewhere. Subsequent functionalization of 1
was achieved using an etherification method described
by Fedorynski et al. (29). The reaction was carried out
in the presence of of potassium carbonate and 18-crown-
6, allowing mild deprotonation of the phenolic compound
1. The alkylating agent was 6-(tert-butyldimethylsiloxy)-
1-iodohexane. It was prepared according to a published
procedure by Heslin et al. (30). Introduction of the hexyl
side chain yielded the PDHD derivative 2 (Scheme 2) in
approximately 80% yield. Subsequent cleavage of the
silyl ether by treatment with tetrabutylammonium fluo-
ride afforded the alcohol 3 (Scheme 2) in good yield. This
compound was then reacted with a 2-cyanoethyl N,N-
diisopropylchlorophosphoramidite (31) in the presence of
N,N-diisopropylethylamine, yielding the desired PDHD-
phosphoramidite 4 (Scheme 2) in 84% yield. Its structure
was verified by complete spectral characterization. Due
to the lability of the dihydrodioxin ring system, the M+
ion of 4 could not be observed using EI or FAB. However,
ESI provided the molecular ion peak, (M + H)+.
The PDHD oligonucleotide conjugate 5 (Scheme 2) was
prepared by standard synthesis of TTTTGTTTT at 1 íM
scale and coupling this oligonucleotide to PDHD-phos-
phoramidite using special precautions and the manual
adjustment of standard synthesis procedures to avoid any
damage of the conjugate by light, acid, or harsh treat-
ment during deprotection (see Experimental Procedures).
The yield after purification through a reversed-phase
column was 191 íg.
The PDHD dication 6 (Scheme 2) was prepared for
comparison of the effects of the free photosensitizer
versus the effects of the conjugate. This synthesis will
be reported elsewhere.
The synthesis of the conjugate 5 was confirmed using
UV-vis, fluorescence, PAGE, and MALDI-TOF. The
200-400 nm spectra of 9T DNA alone, PDHD 6, and the
conjugate 5 were compared. The spectra of the conjugate
has the peaks of both DNA and PDHD (Figure 1),
indicating the presence of both substances in the product.
Covalent linkage of PDHD to the oligonucleotide was
confirmed by electrophoresis of PDHD 6, PDHD 6 with
9T DNA and the conjugate 5 on 8% polyacrylamide 8M
urea gel (Figure 2). DNA and PDHD were visualized by
UV-shadowing. As expected, PDHD in the first lane
migrated out of the gel because it has a positive charge.
Although it is electrostatically bound to DNA, it also
migrated out of the second lane that contained both
PDHD and 9T DNA. The gray band in this lane is 9T
DNA. Only the lane containing the conjugate exhibited
the strong dark blue (about 400-440 nm) fluorescence
that is observed at 420 nm with PDHD alone (Figure 3).
This proves that PDHD is covalently linked to 9T DNA
in the conjugate. Notably, the conjugate migrates more
slowly on the gel because of the higher molecular weight
and because of the lower charge to molecular weight ratio
(PDHD is an approximate equivalent of one and a half
nucleotides with no charge) (Figure 2). The covalent
linkage was clearly confirmed by the MOLDI-TOF spec-
Figure 5. Quantitation of product formation for Figure 4. The
amount of cross-links (Crossl), undamaged 30-mer (30-mer),
specific cleavage in the region between bases A19 and C27
(Spec), damage to G16 (Gmid), and damage in the region
between bases G8 and G11 (Other) was measured by scanning
densitometry. Irradiation times and reagent concentrations are
as indicated.
Figure 6. Irradiation of the target 30A DNA with and without
PDHD 6/conjugate 5 with and without piperidine treatment.
Lanes: (1) GA Maxam-Gilbert reaction of the target, (2) TC
Maxam-Gilbert reaction, (3) target not treated, (4) target
irradiated for 12 h (as the rest of the samples) and treated with
piperidine, (5 and 6) without piperidine treatment, (7 and 8)
with piperidine treatment, (5 and 7) with 10 íM PDHD, and (6
and 8) with 10 íM conjugate.
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trum of the conjugate [(m/z) (M - H)- observed, 3255.1;
calculated, 3256.3].
To assess how PDHD in a conjugate affects DNA-DNA
binding, UV-melting experiments were performed. 30A
was premixed with 30T, 9T, and a conjugate 5 at 1:1
molar ratio in SCP buffer, heated to 98 °C, and cooled
slowly to 4 °C to anneal. Multiple UV-melting curves
were collected, and melting temperatures of duplexes
were determined at the maximum of the calculated dA/
dT curve [data not shown, (32)]. The melting tempera-
ture for the duplex of 30A and 30T was 80.8 °C (ó ) 0.1
°C). The duplex of 30A and 9T melted at 20.1 °C (ó )
0.5 °C). The duplex of 30A and a conjugate 5 had a
melting temperature of 21 °C (ó ) 0.5 °C). This is the
expected result indicating very little, if any, stabilization
of the duplex by the conjugated PDHD.
Irradiation of the ss 30-mer target 30A with and
without a PDHD conjugate 5 and dication PDHD 6 was
performed in SCP buffer for 1-12 h at 350 nm at about
2 mW/cm2 at 4 °C. The concentration of the radioactively
labeled target was constant at 10 nM. The concentration
of the conjugate and photosensitizer was varied from 0
to 10 íM. The reactants were premixed, heated to 55
°C, and cooled to 4 °C at a rate of 1 °C/min and incubated
at 4 °C for 1 h in the dark before irradiation. After
irradiation, the radical reaction was quenched by 10 mM
DTT. Then the sample was treated with 10% piperidine
at 90 °C to cleave the single stranded target at damaged
Figure 7. Irradiation of the target 30A DNA with and without PDHD 6/conjugate 5 in the presence of carrier DNA, at different
concentrations of NaCl and different pH. Lanes: (1) GA Maxam-Gilbert reaction of the target, (2) TC Maxam-Gilbert reaction, (3)
target not treated, (4-6) with 2 íg of calf thymus carrier DNA, (4) target irradiated for 12 h and treated with piperidine (as the rest
of the lanes, unless otherwise indicated), (5 and 7) with 10 íM PDHD, (6 and 8-13) with 10 íM conjugate, (8) 0 M NaCl, (9) 0.1 M
NaCl, (10) 0.25 M NaCl, (11) 0.5 M NaCl, (12) 0.75 M NaCl, (13) 1.0 M NaCl, pH 7.4, (14) pH 6.0, (15) pH 8.8.
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bases. Results were analyzed by electrophoresis on
denaturing polyacrylamide gels. To determine which
bases were damaged, Maxam-Gilbert chemical sequenc-
ing was performed. Two controls were also included: the
target that was not irradiated and the target that was
irradiated and treated with piperidine, to determine the
background cleavage that is not due to PDHD and PDHD
conjugate.
The following can be concluded from Figure 4. Free
PDHD damages specifically only Gs in ss DNA (lane 5
vs lane 3). In contrast, the conjugate specifically cleaves
A21 and C22 (lane 10 vs lane 5). This can be explained
only by ds formation (Scheme 3b). Notably, the conjugate
also specifically damages T7, T10, and A12 (lane 18 vs
lane 17), sites that are consistent with triplex formation
(Scheme 3b). The conjugate protects from nonspecific
cleavage G16, which is in the middle of the binding region
(lane 16 vs lane 15). The conjugate nonspecifically
damages other Gs (G8, G9, and G11 in lane 16 vs lane
15). The conjugate also forms cross-links with the target
forming two new bands of higher MW (30A with a
conjugate via ds formation and 30A with two conjugates
via triplex formation, lane 9).
Damage to the target was quantitated by scanning
densitometry. The total amount of cross-links, undam-
aged 30-mer, specific cleavage in the region between
bases A19 and C27, and damage of G16 and damage in
the region between bases G8 and G11 was estimated
(Figure 5). As time of irradiation was increased from 1/2
to 12 h, cross-links increased from 4 to 26%, specific
damage increased from 2 to 17% (Figures 4 and 5). The
irradiation time for all further studies was set at 12 h.
The concentration of PDHD and the conjugate were
varied in the range 2.5-50 íM. There was little specific
damage and cross-links by the conjugate formed at 2.5
íM concentrations. These products increased at 10 íM
concentrations. Further increases in concentration only
increased nonspecific damage (Figures 4 and 5). Thus,
the concentration of damaging agents was set at 10 íM
for all further experiments.
When ss target was irradiated with PDHD or PDHD
conjugate, but not treated with piperidine, little cleavage
at Gs was observed with free PDHD (lane 5 vs lane 7,
Figure 6), and there were more cross-links than cleavage
with the conjugate (lane 6 vs lane 8, Figure 6). This
indicates that PDHD is damaging Gs, but not cleaving
them, and that the conjugate primarily forms cross-links
that are later partially cleaved by piperidine.
When ss target was irradiated with a large amount of
carrier DNA (2000 carrier, 1 target), PDHD cleaved the
target severalfold less (lane 5 vs lane 7, Figure 7),
indicating complete nonspecificity, while the conjugate
cleaved with almost the same efficiency as it cleaved in
the absence of carrier DNA (lane 6 vs lane 13, Figure 7).
Specific cleavage increased when the concentration of
NaCl was increased (0, 0.1, 0.25, 0.5, 0.75, and 1.0 M in
lanes 8-13, Figure 7, and lanes 10-15, Figure 8). This
is consistent with increased double-strand stability at
higher salt concentrations. Slight variation of pH (7.4,
6.0, and 8.8 in lanes 13-15, Figure 7) did not affect
cleavage significantly. Triplex cleavage was not detected
under these conditions. The maximum site-specific
modification achieved was 67% (51% of cross-links and
16% of direct cleavage) in a sample that was not treated
with piperidine (lane 3, Figure 8).
Four separate irradiations of the target with the
conjugate at standard conditions (10 nM target, 10 íM
conjugate, 12 h of irradiation, piperidine treated) gave
an average of 40% site-specific modifications: 23% (ó )
3%) cross-links and 17% (ó ) 3%) direct cleavage (lanes
5 and 9, Figure 5, and lanes 6 and 15, Figure 8).
While the damage at double-strand formation sites was
always consistent, the damage at triple-strand sites was
observed in a few cases, in conditions where it was
strongly favored. Some evaporation of the samples, even
though compensated by the addition of water, may have
affected product formation.
As compared to other photosensitizers that were
conjugated to DNA (2, 3), PDHD seems to have desirable
qualities. The wavelength of excitation is 350 nm, above
the absorbance of DNA and proteins although still much
shorter than the 700 nm that is more useful for photo-
therapy. PDHD conjugate gives high yields (up to 67%)
of specific damage, which places it second after psoralens
(6) in efficacy of damage. PDHD conjugate is capable of
photo-cross-linking to or damaging all four bases in a
target DNA, while most other sensitizers damage only a
limited set of bases (4, 13). Besides the site-specific
damage, the current generation of PDHD conjugates
induce nonspecific damage of Gs around the targeted
sequence. This can hopefully be eliminated by attaching
the sequence-recognizing unit to the quinone rather than
the olefin-derived moiety, thus preventing damage to
nearby sequences through migration of released PAQ.
In conclusion, the photochemical cleavage studies prove
that the PDHD-oligonucleotide conjugate binds to the
complementary target. It efficiently and site-specifically
cleaves the designated target, thus, the incorporation of
the oligonucleotide sequence recognizing unit onto the
PDHD converts a nonspecific photochemical reagent into
a sequence specific one.
In future studies, the ss PDHD conjugate will be tested
as a selective photochemical M13 virus inactivating agent
by measuring inactivation of the lac i gene. A variety of
improvements of PDHDs are currently under investiga-
tion.
ACKNOWLEDGMENT
We sincerely thank the DNA Core Facility at the
University of Cincinnati for providing all oligonucleotides
and performing the DHD-oligonucleotide coupling reac-
tion. R.M.W. thanks the NSF (CHE-9122141) for finan-
cial support.
LITERATURE CITED
(1) Goodchild, J. (1990) Conjugates of oligonucleotides and
modified oligonucleotides: a review of their synthesis and
properties. Bioconjugate Chem. 1 (3), 165-186.
Figure 8. Quantitation of product formation for Figures 6 and
7. Samples: (1-3) DNA alone, with PDHD and with the
conjugate, no piperidine treatment, (4-6) DNA alone, with
PDHD and with the conjugate, piperidine treated, (7-9) DNA
alone, with PDHD and with the conjugate, with 2 íg of calf
thymus carrier DNA present, 10-15 NaCl concentrations of 0,
0.1, 0.25, 0.5, and 1 M, respectively, (15) pH 7.4, (16) pH 6, (17)
pH 8.8.
562 Bioconjugate Chem., Vol. 9, No. 5, 1998 Bendinskas et al.
(2) Knorre, D. G., and Zarytova, V. F. (1991) Novel antisense
derivatives: antisense DNA intercalators, cleavers, and alkyl-
ators. in Prospects for antisense nucleic acid therapy of cancer
and AIDS (E. Wickstrom, Ed.) pp 195-218, Wiley-Liss, New
York.
(3) Thoung, N. T., and Asseline, U. (1991) Oligonucleotides
attached to intercalators, photoreactive and cleavage agents.
in Oligonucleotides and analogues (F. Eckstein, Ed.) pp 283-
306, IRL-Press, Oxford.
(4) Cimino, G. D., Gamper, H. B., Isaacs, S. T., and Hearst, J.
E. (1985) Psoralens as photoactive probes of nucleic acid
structure and function: Organic chemistry, photochemistry,
and biochemistry. Annu. Rev. Biochem. 54, 1151-1193.
(5) Duval-Valentin, G., Thoung, N. T., and Helene, C. (1992)
Specific inhibition of transcription by triple helix-forming
oligonucleotides. Proc. Natl. Acad. Sci. U.S.A. 89, 504-508.
(6) Kean, J. M., Murakami, A., Blake, K. B., Cushman, C. D.,
and Miller, P. S. (1988) Photochemical cross-linking of
psoralen-derivatized oligonucleoside methylphosphonates to
rabbit globin messenger RNA. Biochemistry 27, 9113-9121.
(7) Giovannangeli, C., Rougee, M., Garestier, T., Thoung, N.
T., and Helene, C. (1992) Triple-helix formation by oligo-
nucleotides containing the three bases thymine, cytosine, and
guanine. Proc. Natl. Acad. Sci. U.S.A. 89, 8631-8635.
(8) Giovannangeli, C., Thoung, N. T., and Helene, C. (1992)
Oligonucleotide-directed photoinduced cross-linking of HIV
proviral DNA via triple-helix formation. Nucleic Acids Res.
20 (16), 4275-4281.
(9) Havre, P. A., Gunther, E. J., Gasparro, F. P., and Glazer,
P. M. (1993) Targeted mutagenesis of DNA using triple helix-
forming oligonucleotides linked to psoralen. Proc. Natl. Acad.
Sci. U.S.A. 90, 7879-7883.
(10) Grigoriev, M., Praseuth, D., Guieysse, A. L., Robin, P.,
Thoung, N. T., Helene, C., and Harel-Bellan, A. (1993)
Inhibition of gene expression by triple helix-directed DNA
cross-linking at specific sites. Proc. Natl. Acad. Sci. U.S.A.
90, 3501-3505.
(11) Doan, T. L., Praseuth, D., Perrouault, L., Chassignol, M.,
Thoung, N. T., and Helene, C. (1990) Sequence-targeted
photochemical modifications of nucleic acids by complemen-
tary oligonucleotides covalently linked to porphyrins. Bio-
conjugate Chem. 1, 108-113.
(12) Vlasov, V. V., Deeva, E. A., Ivanova E. M., Knorre, D. G.,
Maltseva, T. V., and Frolova, E. I. (1991) Photoactivatable
porphyrin oligonucleotide derivatives for sequence specific
chemical modifications and cleavage of DNA. Nucleosides
Nucleotides 10 (1-3), 641-643.
(13) Sessler, J. L., Sansom, P. I., Kral, V., O’Connor, D., and
Iverson, B. L. (1996) Sapphyrin-oligonucleotide conjugates.
Novel sequence-specific DNA photomodifying agents with
increased binding affinity. J. Am. Chem. Soc. 118, 12322-
12330.
(14) Doan, T. L., Perrouault, L., Praseuth, D., Decout, J.-L.,
Habhoub, N., Lhomme, J., Thoung, N. T., and Helene, C.
(1987) Sequence-specific recognition, photo-cross-linking and
cleavage of the DNA double helix by an oligo-[R]-thymidylate
covalently linked to an azidoproflavine derivative. Nucleic
Acids Res. 19, 7749-7760.
(15) Praseuth, D., Perrouault, L., Doan, T. L., Chassignol, M.,
Thoung, N. T., and Helene, C. (1988) Sequence-specific
binding and photo-cross-linking of R- and â-oligodeoxynucle-
otides to the major groove of DNA via triple-helix formation.
Proc. Natl. Acad. Sci. U.S.A. 85, 1349-1353.
(16) Perrouault, L., Asseline, U., Rivalle, C., Thoung, N. T.,
Bisagni, E., Giovannangeli, C., Doan, T. L., and Helene, C.-
(1990) Sequence-specific artificial photoinduced endonucleas-
es based on triple helix-forming oligonucleotides. Nature 344,
358-360.
(17) Durland, R. H., Kessler, D. J., and Hogan, M. (1991)
Antiparallel triplex formation at physiological pH. in Pros-
pects for antisense nucleic acid therapy of cancer and AIDS
(E. Wickstrom, Ed.) pp 219-226, Wiley-Liss, New York.
(18) Praseuth, D., Doan, T. L., Chassignol, M., Decout, J.-L.,
Habhoub, N., Lhomme, J., Thoung, N. T., and Helene, C.
(1988) Sequence-targeted photosensitized reactions in nucleic
acids by oligo-R-deoxynucleotides covalently linked to profla-
vin. Biochemistry 27, 3031-3038.
(19) Hill, A. R., Orgel, L. E. (1991) Photooxidation of oligode-
oxynucleotides by UO22+. Bioconjugate Chem. 2, 431-434.
(20) Geselowitz, D. A., Neumann, R. D. (1995) Quantitation of
triple-helix formation using a photocross-linkable aryl azide/
biotin/oligonucleotide conjugate. Bioconjugate Chem. 6, 502-
506.
(21) Wilson, R. M., Schnapp, K. A., Harsch, A., Keller, S. J.,
and Schlemm, D. J. (1996) Preparation of 1,4-dihydrodioxins
and related compounds as DNA cleaving reagents. PCT Int.
Appl. WO 96 20, 205, (Cl C07h21/00), 4 Jul 1996, US Appl.
365,091, 28 Dec 1994; 67 pp. (Eng.), and personal com-
munications.
(22) Koch, T., Ropp, J. D., Sligar, S. G., and Schuster, G. B.
(1993) Photocleavage of DNA: Irradiation of quinone-contain-
ing reagents converts supercoiled to linear DNA. Photochem.
Photobiol. 58 (4), 554-558.
(23) Armitage, B., You, C., Devadoss, C., and Schuster, G. B.
(1994) Cationic anthraquinone derivatives as catalitic DNA
photonucleases: mechanism for DNA damage and quinone
recycling. J. Am. Chem. Soc. 116 (22), 9847-9859.
(24) Breslin, D. T. and Schuster, G. B. (1996) Anthraquinone
photonucleases: mechanisms for GC-selective and nonselec-
tive cleavage of double-stranded DNA. J. Am. Chem. Soc. 118
(10), 2311-2319.
(25) Ly, D., Kan, Y., Armitage, B., and Schuster, G. B. (1996)
Cleavage of DNA by irradiation of substituted anthraquino-
nes: intercalation promotes electron transfer and efficient
reaction at GG steps. J. Am. Chem. Soc. 118 (36), 8747-8748.
(26) Breslin, D. T., Coury, J. E., Anderson, J. R., McFail-Isom,
L., Kan, Y., Williams, L. D., Bottomley, L. A., and Schuster,
G. B. (1997) Antraquinone photonuclease structure deter-
mines its mode of binding to DNA and the cleavage chemistry
observed. J. Am. Chem. Soc. 119 (21), 5043-5044.
(27) Harsch, A. (1996) Masked ortho-quinones as photoactivated
DNA cleaving agents. Diss. Abstr. Int. 57 (10B), 6263.
(28) Maxam, A. M., and Gilbert W. (1980) Sequencing end-
labeled DNA with base-specific chemical cleavages. Methods
Enzymol. 65, 499.
(29) Fedorynski, M., Wojciechowski, K., Matacz, Z., and Ma-
kosza, M. (1978) Sodium and Potassium Carbonates: Ef-
ficient Strong Bases in Solid-Liquid Two-Phase Systems. J.
Org. Chem. 43, 4682-4684.
(30) Heslin, J. C. and Moody, C. J. (1988) Rhodium Carbenoid
Mediated Cyclisations. Part 2. Synthesis of Cyclic Ethers. J.
Chem. Soc., Perkin Trans. 1, 6, 1417-1423.
(31) Sinha, N. D., Biernat, J., and Koester, H. (1983) b-
CYANOETHYL N,N-Dialkylamino/N-Morpholinomonchloro
Phoshoamidites, New Phosphylating Agents Facilitating Ease
of Deprotection and Workup of Synthesized Oligonucleotides.
Tetrahedron Lett. 24, 5843-5846.
(32) Bendinskas, K. G. (1996) Towards directing photosensi-
tizers to key viral targets using combinatorially selected
oligonucleotides. Diss. Abstr. Int. 58 (03B), 1262.
BC970209A
Phenanthrodihydrodioxin−DNA Conjugate Bioconjugate Chem., Vol. 9, No. 5, 1998 563
